/
Other
Central Nervous System
48
Pipeline Programs↗
61
Active Trials↗
45
Companies Involved↗
Central Nervous System is a moderately active landscape with 48 programs across 45 companies. The most active players are EveryONE Medicines Inc.. 4 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical8
Phase 110
Phase 226
Phase 34
Approved
No programs
Analysis
Modality Breakdown
69%
Small molecule
31 of 45 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 45 classified programs, each share of the total. Modality classified for 100% of 48 pipeline programs.
Analysis
Trial Status
186
clinical trials
Completed74 · 40%
Recruiting41 · 22%
Unknown status24 · 13%
Terminated17 · 9%
Active, not recruiting13 · 7%
Withdrawn9 · 5%
Other8 · 4%
Clinical Trials
Trial Activity
186 trials
Comprehensive Multimodal Analysis of Patients With Neuroimmunological Diseases of the CNS
Recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·N/A·NCT00794352·2,400 enrolled
Page 1 of 13
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)